GRAHAM RICHARD A 4
4 · Theravance Biopharma, Inc. · Filed Aug 22, 2023
Insider Transaction Report
Form 4
GRAHAM RICHARD A
SVP, Development
Transactions
- Tax Payment
Ordinary Shares
2023-08-20$9.70/sh−10,461$101,472→ 339,285 total
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.